Tiragolumab (Genetical Recombination)



Tiragolumab is a recombinant human IgG1 monoclonal antibody against human T-cell immunoreceptor with Ig and ITIM domains (TIGIT). Tiragolumab is produced in Chinese hamster ovary cells. Tiragolumab is a glycoprotein (molecular weight: ca. 151,000) composed of 2 H-chains (γ1-chains) consisting of 456 amino acid residues each and 2 L-chains (κ-chains) consisting of 220 amino acid residues each.

[1918185-84-8]